MDT · News · 20260917N
Hugo Robotic Surgery Expansion
Medtronic plc · 2026-09-17 · Importance 38 · Surprise 60 · In source text
The FDA cleared Medtronic’s LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery system in the United States. The clearance brings LigaSure vessel-sealing and cutting technology to U.S. robotic-assisted procedures, initially emphasizing urologic surgery and later expansion to other soft-tissue procedures. The device was already available in Europe, supporting Medtronic’s effort to broaden Hugo’s instrument portfolio and compete for robotic-surgery market share.
Key facts
- The FDA has cleared Medtronic's LigaSure RAS Maryland jaw device for use with its Hugo robotic-assisted surgery (RAS) system in the US. source
- Medtronic has received FDA clearance for its LigaSure vessel-sealing technology to be used with its Hugo soft tissue robotic surgery system. source
- Medtronic plans to expand indications for the LigaSure RAS Maryland device to other soft-tissue procedures. source
- The LigaSure RAS Maryland device is already available in Europe. source
- Medtronic is expanding its robotic-assisted surgery capabilities. source
- The LigaSure RAS Maryland device is designed for efficient vessel sealing and cutting with reduced thermal spread. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | The FDA has cleared Medtronic's LigaSure RAS Maryland jaw device for use with its Hugo robotic-assisted surgery (RAS) system in the US. |
| revenue | positive | probable | — | Medtronic has received FDA clearance for its LigaSure vessel-sealing technology to be used with its Hugo soft tissue robotic surgery system. |